TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...
Edgewise Therapeutics Inc. (NASDAQ:EWTX) on Tuesday released topline results from the 12-week Part D cohort of its Phase 2 ...
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact on survival among people living with multiple myeloma, ...
From cholesterol-lowering statins to blood pressure pills and heart failure treatments, cardiovascular medications come in many types, each with unique benefits, risks, and uses. Knowing how they work ...
Aficamten shows cardiac benefits over blood pressure drug metoprolol Analysts see potential for aficamten to replace beta-blocker drugs for treating HCM Cytokinetics plans to submit data to regulators ...
People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease.
When the results of the SELECT trial landed in the New England Journal of Medicine in November 2023, they confirmed what cardiologists had been hoping to see for years: a weekly injection of ...
Entresto (sacubitril/valsartan) is a brand-name drug prescribed for certain types of heart failure. This article covers topics such as side effects, dosage, and how ...
Internal organ tissues often don’t heal after illness or injury and lose some function, such as the heart after a heart attack. UCLA cardiologists have identified a protein that interferes with ...
In their analysis, the authors evaluated the effects of commonly used cardiovascular medications in patients with multiple myeloma. These widely prescribed drugs, used to manage high blood pressure, ...
Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of patients with multiple myeloma. SHARJAH, EMIRATE OF ...